We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
16.9
quarters
Top 10 Avg Time Held Equity + Options
5.9
quarters
Top 20 Avg Time Held Equity + Options
16.1
quarters
Avg Time Held Equity only
16.9
quarters
Top 10 Avg Time Held Equity only
5.9
quarters
Top 20 Avg Time Held Equity only
16.1
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3801
Surgery Partners
SGRY
$1.85B
| $158K | ﹤0.01% |
+13,253
| New | +$190K |
2026 Q1
0 quarters
|
|
3802
Adamas Trust
ADAM
$692M
| $158K | ﹤0.01% |
21,462
+2,910
| +16% | +$23.2K |
2025 Q3
2 quarters
|
|
3803
Sinclair Inc
SBGI
$913M
| $158K | ﹤0.01% |
12,173
+15
| +0.1% | +$218 |
2025 Q3
2 quarters
|
|
3804
Digimarc Corp
DMRC
$144M
| $157K | ﹤0.01% |
31,879
+6,094
| +24% | +$33.8K |
2025 Q4
1 quarter
|
|
3805
Enanta Pharmaceuticals
ENTA
$357M
| $155K | ﹤0.01% |
+12,245
| New | +$164K |
2026 Q1
0 quarters
|
|
3806
Candel Therapeutics
CADL
$754M
| $154K | ﹤0.01% |
+31,398
| New | +$171K |
2026 Q1
0 quarters
|
|
3807
AbCellera Biologics
ABCL
$4.08B
| $154K | ﹤0.01% |
44,051
+2,207
| +5% | +$7.94K |
2024 Q3
6 quarters
|
|
3808
Rackspace Technology
RXT
$940M
| $153K | ﹤0.01% |
+155,870
| New | +$189K |
2026 Q1
0 quarters
|
|
3809
Rayonier Advanced Materials
RYAM
$486M
| $152K | ﹤0.01% |
+13,769
| New | +$124K |
2026 Q1
0 quarters
|
|
3810
Ardagh Metal Packaging
AMBP
$2.59B
| $152K | ﹤0.01% |
37,593
-6,045
| -14% | -$26.8K |
2025 Q2
3 quarters
|
|
3811
Virtus Total Return Fund
ZTR
$310M
| $152K | ﹤0.01% |
22,992
-1,216
| -5% | -$8.07K |
2025 Q4
1 quarter
|
|
3812
Cerus
CERS
$451M
| $152K | ﹤0.01% |
83,376
+47,862
| +135% | +$104K |
2025 Q3
2 quarters
|
|
3813
National CineMedia
NCMI
$200M
| $151K | ﹤0.01% |
49,645
-44,816
| -47% | -$157K |
2025 Q3
2 quarters
|
|
3814
DELISTED
Cross Country Healthcare
CCRN
| $149K | ﹤0.01% |
15,806
-9,179
| -37% | -$82.2K |
2025 Q2
3 quarters
|
|
3815
Sunstone Hotel Investors
SHO
$2.13B
| $149K | ﹤0.01% |
16,485
-1,063
| -6% | -$9.76K |
2025 Q2
3 quarters
|
|
3816
Harmonic Inc
HLIT
$1.15B
| $149K | ﹤0.01% |
16,538
-16,385
| -50% | -$163K |
2025 Q4
1 quarter
|
|
3817
Lucid Motors
LCID
$1.36B
| $148K | ﹤0.01% |
15,582
+2,514
| +19% | +$26.1K |
2021 Q1
20 quarters
|
|
3818
Puma Biotechnology
PBYI
$535M
| $148K | ﹤0.01% |
+23,113
| New | +$149K |
2026 Q1
0 quarters
|
|
3819
Aeva Technologies
AEVA
$855M
| $147K | ﹤0.01% |
+11,136
| New | +$166K |
2026 Q1
0 quarters
|
|
3820
RLX Technology
RLX
$2.11B
| $146K | ﹤0.01% |
66,409
-1,426
| -2% | -$3.28K |
2022 Q3
14 quarters
|
|
3821
ThredUp
TDUP
$323M
| $146K | ﹤0.01% |
+44,474
| New | +$206K |
2026 Q1
0 quarters
|
|
3822
John Hancock Premium Dividend Fund
PDT
$589M
| $145K | ﹤0.01% |
11,101
-358
| -3% | -$4.69K |
2025 Q4
1 quarter
|
|
3823
abrdn Emerging Markets Equity Income Fund
AEF
$375M
| $145K | ﹤0.01% |
19,910
+8,177
| +70% | +$63.9K |
2025 Q2
3 quarters
|
|
3824
Stagwell
STGW
$2.15B
| $145K | ﹤0.01% |
23,009
-11,109
| -33% | -$62.1K |
2023 Q4
9 quarters
|
|
3825
DELISTED
Cantaloupe
CTLP
| $144K | ﹤0.01% |
13,279
-15
| -0.1% | -$159 |
2025 Q2
3 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.